Von Hippel-Lindau Disease
Authors:
P. Plevová 1; J. Novotný 2; A. Křepelová 3
Authors‘ workplace:
Ústav patologie & Laboratoř molekulární patologie LF UP Olomouc 2Institut onkologie a rehabilitace Na Pleši s. r. o., Nová Ves pod Pleší 3Ústav biologie a lékařské genetiky FN Motol a 2 LF UK Praha
; Oddělení lékařské genetiky FN Ostrava
1
Published in:
Klin Onkol 2009; 22(Supplementum): 23-24
Sources
1. Glasker S, Bender BU, Apel TW et al. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system. J Neurosurg Psychiatry 1999; 67 : 758–762.
2. Hes F, Zewald R, Peeters T et al. Genotyp-phenotype correlation in families with deletions in the von Hippel-Lindau gene. Human Genet 2000; 106 : 423–431.
3. http://www.mdanderson.org/diseases/vhl/ (Texaská univerzita, MD Anderson Cancer Center).
4. Lindor NM, Greene MH a Mayo Familial Cancer Program. The concise handbook of family cancer syndromes. J Natl Cancer Inst 1998; 90 : 1067–1068.
5. Maher ER, Kaelin WG. Von Hippel-Lindau Disease. Medicine 1997; 76 : 381–391.
6. www.vhl.org (Massachusetts General Hospital Cancer Center)
Labels
Paediatric clinical oncology Surgery Clinical oncologyArticle was published in
Clinical Oncology
2009 Issue Supplementum
- Metamizole vs. Tramadol in Postoperative Analgesia
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Possibilities of Using Metamizole in the Treatment of Acute Primary Headaches
- Spasmolytic Effect of Metamizole
- Safety and Tolerance of Metamizole in Postoperative Analgesia in Children
Most read in this issue
- Hereditary Pancreatitis
- Gorlin Syndrome
- Multiple Endocrine Neoplasia Type 2 Syndrome
- Multiple Endocrine Neoplasia Type 1 Syndrome